Table 3 Agreement between actual prescribing of ICS/LABA for 59 COPD patients (FEV 1 /FVC <0.7) with no concomitant diagnosis of asthma in 2009/10 and the prescribing recommended based on the 2007–2010 GOLD guidelines
From: Predictors of ICS/LABA prescribing in COPD patients: a study from general practice
ICS/LABA recommended (FEV1% predicted <50 and previous exacerbation) | |||
|---|---|---|---|
ICS/LABA | Yes | No | |
Prescribed 2009/10 | |||
Yes | 9 | 14 | 23 |
No | 2 | 34 | 36 |
11 | 48 | 59 | |
Kappa = 0.37 (SE 0.12) | |||